Honokiol DCA

• Description :

  Honokiol DCA (Honokiol dichloroacetate) is a dichloroacetate analog of Honokiol. Honokiol DCA can inhibit the growth of human prostate cancer cells in vitro and suppress the androgen receptor (AR) protein level[1].

• Product Name Alternative :

  Honokiol dichloroacetate

• UNSPSC :

  12352005

• Target :

  Androgen Receptor

• Type :

  Reference compound

• Related Pathways :

  Vitamin D Related/Nuclear Receptor

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/honokiol-dca.html

• Purity :

  98.01

• Solubility :

  DMSO : 100 mg/mL (ultrasonic)

• Smiles :

  O=C(C(Cl)Cl)OC1=CC=C(CC=C)C=C1C2=CC(CC=C)=C(OC(C(Cl)Cl)=O)C=C2

• Molecular Formula :

  C22H18Cl4O4

• Molecular Weight :

  488.19

• References & Citations :

  [1]Hahm ER, et, al. Honokiol inhibits androgen receptor activity in prostate cancer cells. Prostate. 2014 Apr;74 (4) :408-20.

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -20°C (Powder, protect from light)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [1620160-42-0]